CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
Pharmacy PHA
Ensuring Safe Access to Prescription Medication Act of 2014 S.2825
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
Health Issues HCR
general health issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; biosimilars; Stop Tampering of Prescription Pills Act of 2013 (H.R. 486) Safeguarding America's Pharmaceuticals Act of 2013; Able Act H.R. 647; Medicaid Generic Drug Price Fairness Act H.R.5748, S.2984
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
Taxation/Internal Revenue Code TAX
Medical Device Tax Repeal; Stop Corporate Inversions Act S. 2360, H.R. 4679; issues relating to incentive for life sciences research' Protect Medical Innovation Act of 2013 S.232, H.R.523
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| BILL K BREWSTER | — |
| DAVID JORY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.